FDA Urges Congress to Renew User Fee Programs to Protect Drug Approval Process
Food and Drug Administration officials are urging Congress to reauthorize key industry-funded programs, warning that failure to act could disrupt approvals for new medicines, medical treatments and digital health technologies.